PREDOMINANT CUTANEOUS INFILTRATION BY OKT6- AND OKT8-POSITIVE CELLS IN A CASE OF SEZARY SYNDROMEMEISSNER K; LOENING T; HECKMAYR M et al.1983; ARCHIVES FOR DERMATOLOGICAL RESEARCH; ISSN 0340-3696; DEU; DA. 1983; VOL. 275; NO 3; PP. 168-174; BIBL. 48 REF.Article

A TECHNIQUE FOR IMMUNOULTRASTRUCTURAL IDENTIFICATION OF T6-POSITIVE LANGERHANS CELLS AND INDETERMINATE CELLS IN MYCOSIS FUNGOIDESHOLDEN CA; MORGAN EW; MACDONALD DM et al.1982; JOURNAL OF INVESTIGATIVE DERMATOLOGY; ISSN 0022-202X; USA; DA. 1982; VOL. 79; NO 6; PP. 382-384; BIBL. 13 REF.Article

DEMONSTRATION OF OKT6-REACTIVE CELLS IN MYCOSIS FUNGOIDESMCMILLAN EM; BEEMAN K; WASIK R et al.1982; J. AM. ACAD. DERMATOL.; ISSN 0190-9622; USA; DA. 1982; VOL. 6; NO 5; PP. 880-887; BIBL. 35 REF.Article

IN SITU DEMONSTRATION OF OKT 6-POSITIVE CELLS IN CUTANEOUS LYMPHOID INFILTRATESMCMILLAN EM; WASIK R; EVERETT MA et al.1981; J. AM. ACAD. DERMATOL.; ISSN 0190-9622; USA; DA. 1981; VOL. 5; NO 3; PP. 274-279; BIBL. 17 REF.Article

Mycosis fungoides: detection of OKT6⁺ cells by cytofluorographic analysis in one caseCINTORINO, M; DEL VECCHIO, M. T; DE SANTI, M. M et al.The American journal of dermatopathology. 1987, Vol 9, Num 2, pp 114-119, issn 0193-1091Article

Expression of OKT6 antigen by Langerhans cells in patch test reactionsCHRISTENSEN, O. B; DANIELS, T. E; MAIBACH, H. I et al.Contact dermatitis. 1986, Vol 14, Num 1, pp 26-31, issn 0105-1873Article

Observations on Langerhans' cells in leposy using monoclonal antibody OKT6LIU JI-HE; SHI YUAN-FU; KONG QING-YING et al.International journal of leprosy. 1984, Vol 52, Num 4, pp 524-526, issn 0020-7349Article

Quantitative analysis of T6-positive Langerhans cells in human skin cancersMEISSNER, K; HAFTEK, M; ARLOT, M et al.Virchows Archiv. A, Pathological anatomy and histopathology. 1986, Vol 410, Num 1, pp 57-63, issn 0174-7398Article

Biochemical characterization of the human T6 antigen: a comparison between T6 and murine TLBUSHKIN, Y; CHORNEY, M. J; DIAMANTE, E et al.Molecular immunology. 1984, Vol 21, Num 10, pp 821-829, issn 0161-5890Article

Flow cytometric quantification of T6-positive cells in psoriatic epidermis after PUVA and methotrexate therapyGOMMANS, J. M; VAN HEZIK, S. J. T. M; VAN HUYSTEE, B. E. W. L et al.British journal of dermatology (1951). 1987, Vol 116, Num 5, pp 661-666, issn 0007-0963Article

IDENTIFICATION OF LANGERHANS CELLS: SIMULTANEOUS USE OF SERA TO INTERMEDIATE FILAMENTS, T6 AND HLA-DR ANTIGENS ON ORAL MUCOSA, HUMAN EPIDERMIS AND THEIR TUMOURSLOENING T; CASELITZ J; SEIFERT G et al.1982; VIRCHOWS ARCHIV. A. PATHOLOGICAL ANATOMY AND HISTOLOGY; ISSN 0340-1227; DEU; DA. 1982; VOL. 398; NO 2; PP. 119-128; BIBL. 2 P.Article

Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in manFAURE, M; FRAPPAZ, A; SCHMITT, D et al.Cellular immunology (Print). 1984, Vol 83, Num 2, pp 271-279, issn 0008-8749Article

Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinantsFOSTER, C. A; HOLBROOK, K. A; FARR, A. G et al.Journal of investigative dermatology. 1986, Vol 86, Num 3, pp 240-243, issn 0022-202XArticle

Eosinophilic granuloma: presence of OKT6-positive cells and good response to intralesional steroidHASHIMOTO, K; TAKAHASHI, S; FLIGIEL, A et al.Archives of dermatology (1960). 1985, Vol 121, Num 6, pp 770-774, issn 0003-987XArticle

Evaluation of four CD22 antibodies as ricin a chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomasGUO-LIANG SHEN; JIA-LING LI; JANOSSY, G et al.International journal of cancer. 1988, Vol 42, Num 5, pp 792-797, issn 0020-7136Article

A monoclonal antibody (GF 22-1) detecting different patterns of HLA class I cross-reactivities at different dilutionsSENSI, A; BARICORDI, O. R; MELCHIORRI, L et al.Tissue antigens. 1985, Vol 26, Num 3, pp 204-209, issn 0001-2815Article

Heterogeneity of the respiratory syncytial virus 22K protein revealed by Western blotting with monoclonal antibodiesROUTLEDGE, E. G; WILLCOCKS, M. M; MORGAN, L et al.Journal of general virology. 1987, Vol 68, Num 4, pp 1209-1215, issn 0022-1317Article

Immunotherapy in a spontaneously developed murine mammary carcinoma with syngeneic monoclonal antibodyCAPONE, P. M; KADOHAMA, N; MING CHU, T et al.Cancer immunology and immunotherapy. 1987, Vol 25, Num 2, pp 93-99, issn 0340-7004Article

Application of antibody to synthetic peptides for characterization of the intact and truncared 22 protein specified by herpes simplex virus 1 and the R325 α22^- deletion mutantACKERMANN, M; SARMINETO, M; ROIZMAN, B et al.Journal of virology. 1985, Vol 56, Num 1, pp 207-215, issn 0022-538XArticle

Monoclonal antibody therapies in leukemiasTALLMAN, Martin S.Seminars in hematology. 2002, Vol 39, Num 4, pp 12-19, issn 0037-1963, 8 p., SUP3Article

IMMUNOLOCALIZATION OF KERATIN POLYPEPTIDES IN HUMAN EPIDERMIS USING MONOCLONAL ANTIBODIES = LOCALISATION IMMUNOLOGIQUE DES POLYPEPTIDES DE KERATINE DANS L'EPIDERME HUMAIN A L'AIDE D'ANTICORPS MONOCLONAUXWOODCOCK MITCHELL J; EICHNER R; NELSON WG et al.1982; J. CELL BIOL.; ISSN 0021-9525; USA; DA. 1982; VOL. 95; NO 2; PART. 1; PP. 580-588; BIBL. 55 REF.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

STUDIES OF A HIGH MOLECULAR WEIGHT HUMAN MELANOMA-ASSOCIATED ANTIGEN = ETUDES D'UN ANTIGENE DE HAUT POIDS MOLECULAIRE ASSOCIE AU MELANOME HUMAINHELLSTROEM I; GARRIGUES HJ; CABASCO L et al.1983; JOURNAL OF IMMUNOLOGY; ISSN 0022-1767; USA; DA. 1983; VOL. 130; NO 3; PP. 1467-1472; ABS. ENG; BIBL. 26 REF.; GRAPH, FIGArticle

Leu-22: a preferential marker for T-lymphocytes in paraffin sections: staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processesSAID, J. W; STOLL, P. N; SHINTAKU, P et al.American journal of clinical pathology. 1989, Vol 91, Num 5, pp 542-549, issn 0002-9173Article

ANTIGENIC HETEROGENEITY OF SURGICALLY REMOVED PRIMARY AND AUTOLOGOUS METASTATIC HUMAN MELANOMA LESIONS = HETEROGENEITE ANTIGENIQUE DES LESIONS PRIMAIRES ET METASTATIQUES AUTOLOGUES HUMAIN PRELEVEES CHIRURGICALEMENTNATALI PG; CAVALIERE R; BIGOTTI A et al.1983; JOURNAL OF IMMUNOLOGY; ISSN 0022-1767; USA; DA. 1983; VOL. 130; NO 3; PP. 1462-1466; ABS. ENG; BIBL. 27 REF.; FIGArticle